Dare Bioscience DARE
NASDAQ DARE
$0.68 -0.01 (-1.26%)
As of: Oct 21, 2026 · 3:49 PM EDT

Dare Bioscience (DARE) Capital Leases (2025)

Updated

Dare Bioscience (DARE) posted Capital Leases of $165,186 for Q3 2025, up 0.5% from the prior quarter.

Analysis

Dare Bioscience (DARE) Capital Leases (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Dare Bioscience 10.13 Mn -55.33 Mn -132,343.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 165,186.00
Jun 30, 2025 164,412.00
Mar 31, 2025 649,935.00
API Access

Dare Bioscience Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=DARE&period=max&api_key=YOUR_API_KEY